INTERSTITIAL LUNG DISEASES

This study tests a medicine called nerandomilast for people with lung scarring caused by autoimmune diseases like rheumatoid arthritis or scleroderma. About 400 adults whose lung function hasn't improved with standard treatment will take either the study drug or a placebo for at …

This study tests whether anlotinib capsules can improve lung function in people with idiopathic pulmonary fibrosis (IPF) or progressive fibrosis-interstitial lung diseases (PF-ILDs). About 30 adults aged 40-85 will receive either anlotinib or a placebo. The main goal is to see if…

This study tests whether the drug nerandomilast can slow or prevent lung scarring in people aged 40 and older who have early lung changes and a family history of pulmonary fibrosis. About 80 participants will take either nerandomilast or a placebo twice daily for up to 3 years. D…

This study aims to see if a special, low-dose CT scan can better detect both lung and heart problems in people with interstitial lung disease (ILD). Heart issues are common in ILD but often missed until they become serious. By scanning 123 adults with ILD, researchers hope to cre…

This study will follow 3,000 children and adults with interstitial lung disease (ILD), including their relatives, for up to 10 years. Researchers will collect medical data, genetic information, and test results to better understand how the disease develops and progresses. The goa…

This study aims to better understand the patterns seen on lung ultrasound scans in people with chronic lung diseases. Researchers will enroll 25 adult patients with conditions like COPD or interstitial lung disease. They will compare ultrasound images with other breathing measure…